FDA issues GRAS no objection letter for Sweegen's Bestevia Reb-M - which starts with the leaf, then undergoes 'enzymatic conversion'

California-based SweeGen has received a GRAS no objections letter from the FDA for the use of its Bestevia branded Reb-M - manufactured from stevia leaf extracts converted to Reb M using enzymes – for use as a general purpose sweetener for food and beverage applications in the US.